Methotrexate Cuts Systolic BP in Rheumatoid Arthritis
No significant differences seen in diastolic blood pressure, augmentation index, DAS28-CRP
Features of Immunesenescence Present in Early Stages of Rheumatoid Arthritis
IMM-AGE score and other hallmarks of aging were raised in patients during early stages of rheumatoid arthritis
Benefits of Long-Term Routine Lab Drug Toxicity Monitoring Unclear in RA
New very abnormal results mostly occur after DMARD dose increase, often already known or suspected
FDA Approves Sublingual, Nonopioid Daily Treatment for Fibromyalgia
Tonmya is the first FDA-approved therapy for the treatment of fibromyalgia in more than 15 years
Autoimmune Diseases Linked to Digestive System Cancers
Positive associations seen for celiac disease, SLE, T1D with pancreatic, esophageal, colon, liver, and hepatobiliary cancers
Lupus Low Disease Activity State Attainable in Lupus Nephritis
Independent association seen for complete or partial renal response and lupus low disease activity state with lupus nephritis relapse risk reduction
FDA Approves SetPoint Neuroimmune Modulation Device for Rheumatoid Arthritis
The implantable neurostimulation device activates the body's innate anti-inflammatory and immune-restorative pathways
Cognitive Functional Therapy Effective for Chronic Low Back Pain at Three Years
Cognitive functional therapy, with or without biofeedback, more effective than usual care for chronic disabling low back pain
FDA Publishes Full Texts of Response Letters to Drug Applications
The goal is to improve public understanding of the FDA decision-making process
Novel Exercise May Aid Rheumatoid Arthritis Outcomes
Blood flow-restricted resistance training improves strength and physical performance while reducing perceived pain
